Kayne Anderson Rudnick Investment Management LLC Crispr Therapeutics Ag Transaction History
Kayne Anderson Rudnick Investment Management LLC
- $39.8 Billion
- Q2 2025
A detailed history of Kayne Anderson Rudnick Investment Management LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Kayne Anderson Rudnick Investment Management LLC holds 14 shares of CRSP stock, worth $772. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14
Previous 14
-0.0%
Holding current value
$772
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CRSP
# of Institutions
538Shares Held
68.8MCall Options Held
3.6MPut Options Held
2.3M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl9.79MShares$540 Million4.45% of portfolio
-
Capital International Investors Los Angeles, CA5.59MShares$309 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.68MShares$203 Million0.11% of portfolio
-
State Street Corp Boston, MA3.27MShares$181 Million0.01% of portfolio
-
Ubs Group Ag2.84MShares$157 Million0.02% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $4.31B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....